NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
08/27/2024
Back to search
Official data from USPTO
CORETOX
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: US
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
9
Latest update
08/27/2024
Classification
Registered
Trademark type
Word
Nice classes
5
Filing date
11/30/2023
Registration date
08/27/2024
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
08/27/2024
Last transaction
08/27/2024
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
03
Owner location
Chungcheongbuk-do, KR
Examiner
BEAUDRY-TORRES, FAITH
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
Medytox Inc.
Representatives
Mark J. Liss Leydig, Voit & Mayer, Ltd.
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical and veterinary preparations for the treatment of cerebral palsyheadachesmigrainesophthalmological disordershyperhidrosisacne; muscle relaxants; therapeutic drugs and agents for the treatment of orthopaedic disordership dislocationspinal column deformationcurvature of the spinescoliosislordosiskyphosis; pharmaceutical preparations for treating the peripheral nervous system; bacterial poisons; pharmacological preparations for skin care; pharmaceutical agents for treating the epidermis; injectable dermal filler; pharmaceutical preparations for treating the central nervous system; pharmaceutical preparations for the treatment of muscle fatigue; vaccines
Publications
History of USPTO decisions and trademark events.
9 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
08/27/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
06/11/2024
PUBO
PUBLISHED FOR OPPOSITION
06/11/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
05/22/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
05/08/2024
DOCK
ASSIGNED TO EXAMINER
04/26/2024
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
02/23/2024
NWAP
NEW APPLICATION ENTERED
11/30/2023
Continuous trademark protection
Get notified about every new filing that threatens CORETOX or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.